PKE is trading 10.1% down at $32.74 following a sharp post-earnings reversal as investors weigh soft forward guidance against strong headline growth.

  • While Q4 FY2026 revenue rose 43% year-over-year and EPS more than tripled, management highlighted a lower-margin product mix that pressured profitability outlooks.
  • Q1 FY2027 sales guidance of $20–22 million implies a sequential dip, triggering a classic sell the news reaction after the stock's extended run into the release.